Hepatitis B Virus DNA Integration in Hepatocellular Carcinoma After Interferon-Induced Disappearance of Hepatitis C Virus

Tamori, Akihiro; Nishiguchi, Shuhei; Shiomi, Susumu; Hayashi, Takehiro; Kobayashi, Sawako; Habu, Daiki; Takeda, Tadashi; Seki, Shuichi; Hirohashi, Kazuhiro; Tanaka, Hiromu; Kubo, Shoji
August 2005
American Journal of Gastroenterology;Aug2005, Vol. 100 Issue 8, p1748
Academic Journal
OBJECTIVES: Hepatocellular carcinoma (HCC) has been reported in patients in whom hepatitis C virus (HCV) was eliminated by interferon (IFN) therapy. We examined the pathogenesis of HCC in patients with sustained viral response. METHODS: Operable HCC developed in 7 of 342 patients cured of HCV infection by IFN monotherapy. No patient abused alcohol or had diabetes mellitus or obesity. Resected specimens of HCC were histologically evaluated. DNA extracted from HCC was examined by polymerase chain reaction (PCR) to locate hepatitis B virus (HBV) DNA. HBV integration sites in human genome were identified by cassette-ligation-mediated PCR. RESULTS: HBV DNA was not amplified in serum samples from any of the seven patients with HCC and was found in liver in four patients. In the latter four patients, HBV DNA was integrated into the human genome of HCC. In two of these patients, covalently closed circular HBV (cccHBV) was also detected. The patients with HBV DNA integration were free of HCV for more than 3 yr. In two of the three patients without HBV DNA integration, the surrounding liver showed cirrhosis. The liver of HCC with HBV DNA integration had not progressed to cirrhosis. Three of the four tumors with HBV integration had one integration site each, located at chromosomes 11q12, 11q22-23, and 22q11, respectively. The other tumor had two integration sites, situated at chromosomes 11q13 and 14q32. At chromosome 11q12, HBV DNA was integrated into protein-coding genome, the function of which remains unclear. CONCLUSION: Integrated HBV DNA may play a role in hepatocarcinogenesis after the clearance of HCV by IFN treatment. (Am J Gastroenterol 2005;100:1–6)


Related Articles

  • Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma: a longterm cohort study of 892 patients with viral cirrhosis. Kenji Ikeda; Yasuji Arase; Masahiro Kobayashi; Satoshi Saitohi, Marisa; Takashi Someya; Tetsuya Hosaka; Yoshiyuki Suzuki; Fumitaka Suzuki; Akihito Tsubota; Norio Akuta; Hiromitsu Kumada // Journal of Gastroenterology;2003, Vol. 38 Issue 9, p865 

    Background. Tumor recurrence is common after potentially curative ablation of hepatocellular carcinoma; therefore, the incidence of intrahepatic metastasis and multicentric carcinogenesis was evaluated. Methods. A cohort of 892 patients with cirrhosis caused by either hepatitis B virus (n =246)...

  • Epidemiology of Hepatitis C Virus Infection in Highly Endemic HBV Areas in China. Duan Li; Yong Long; Tingcai Wang; Dan Xiao; Jingxia Zhang; Zhiwen Guo; Bo Wang; Yongping Yan // PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1 

    Background: Wuwei City has the highest prevalence of hepatitis B virus (HBV) in China. From 2007 to 2011, the average reported incidence rate of hepatitis B was 634.56/100,000 people. However, studies assessing the epidemic features and risk factors of HCV in the general population of Wuwei City...

  • Overview. Brechot, C. // Oncogene;6/26/2006, Vol. 25 Issue 27, p3755 

    The article provides information about hepatocellular carcinoma (HCC), a histopathological form of primary liver cancer. HCC is a major long-term complication of chronic hepatitis and cirrhosis. Research on hepatitis B virus and hepatitis C virus-related liver carcinogenesis have enabled...

  • Hepatitis B Virus Genotype and DNA Level in HCC.  // JNCI: Journal of the National Cancer Institute;2/16/2005, Vol. 97 Issue 4, p241 

    Reports on the findings that chronic hepatitis B virus (HBV) infection is a cause of hepatocellular carcinoma (HCC). Methods used to determine the role of HCC in HBV; Results that suggest measurements of HBV load and genotype may help to define which male HBV carriers are at high risk for HCC;...

  • Studies on liver cancer: evolution and perspectives. TANG Zhaoyou // Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi;2014, Vol. 30 Issue 3, p193 

    Great changes have taken place in the studies on liver cancer over the past 50 years. The main evolution and perspectives are re-viewed as follows : ( 1 ) Infections with hepatitis B virus and hepatitis C virus, environmental factors, lifestyle, and metabolic, endocrine, and hereditary factors...

  • Multi-TGDR, a multi-class regularization method, identifies the metabolic profiles of hepatocellular carcinoma and cirrhosis infected with hepatitis B or hepatitis C virus. Suyan Tian; Chang, Howard H.; Chi Wang; Jing Jiang; Xiaomei Wang; Junqi Niu // BMC Bioinformatics;2014, Vol. 15 Issue 1, p1 

    Background Over the last decade, metabolomics has evolved into a mainstream enterprise utilized by many laboratories globally. Like other "omics" data, metabolomics data has the characteristics of a smaller sample size compared to the number of features evaluated. Thus the selection of an...

  • Hepatitis B Virus X Protein Impairs Hepatic Insulin Signaling Through Degradation of IRS1 and Induction of SOCS3. KyeongJin Kim; Kook Hwan Kim; JaeHun Cheong // PLoS ONE;2010, Vol. 5 Issue 3, p1 

    Background: Hepatitis B virus (HBV) is a major cause of chronic liver diseases, and frequently results in hepatitis, cirrhosis, and ultimately hepatocellular carcinoma. The role of HCV in associations with insulin signaling has been elucidated. However, the pathogenesis of HBV-associated insulin...

  • Hepatitis C virus NS2/3 protease regulates HCV IRES-dependent translation and NS5B RdRp activity. Yinglong She; Tao Han; Linbai Ye; Zhenghui Wu // Archives of Virology;Sep2009, Vol. 154 Issue 9, p1465 

    Chronic hepatitis C virus (HCV) infection often leads to liver cancer. NS2/3 protease is the first of two virally encoded proteases required for HCV polyprotein processing. In this report, we investigated the function of NS2/3 protease on HCV replication and translation. Cells transfected with...

  • Response to Lamivudine Treatment in Children with Chronic Hepatitis B Virus Infection. Hagmann, Stefan; Chung, May; Rochford, Gemma; Jani, Mudra; Trinh-Shevrin, Chau; Sitnitskaya, Yekaterina; Neumann, Avidan U.; Pollack, Henry // Clinical Infectious Diseases;12/1/2003, Vol. 37 Issue 11, p1434 

    Despite the recent approval of lamivudine for the treatment of children with chronic hepatitis B virus (HBV) infection, there is insufficient information on the kinetics of HBV clearance and the factors that predict a favorable treatment response to lamivudine in this population. In a small...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics